Redox regulation of protein damage in plasma

Redox Biology

Volumn 2, Issue 1, 2014, Pages 430-435

  Griffiths, Helen R ^a   Dias, Irundika H K ^a   Willetts, Rachel S ^a   Devitt, Andrew ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Ageing; Glycosylation; Nitration; Oxidation; Peroxiredoxin; Thioredoxin

Indexed keywords

ALBUMIN; CYTOKINE; GLUCOSE; IMMUNOGLOBULIN; LIPID; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; OXYGENASE; PLASMA PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RECEPTOR PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE OXIDASE; ISOPROTEIN; LIPOXYGENASE; OXIDOREDUCTASE; PEROXIDASE; PEROXIREDOXIN; THIOREDOXIN;

ANTIBODY AFFINITY; AUTOOXIDATION; CELL COMPARTMENTALIZATION; CELL STRESS; CELL VACUOLE; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; GLUCOSE OXIDATION; HUMAN; LIPID OXIDATION; MASS SPECTROMETRY; METABOLIC REGULATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM; REVIEW; AGING; ANIMAL; BLOOD; ENDOPLASMIC RETICULUM; GLYCOSYLATION; KUPFFER CELL; METABOLISM; NITROSATION; PHYSIOLOGY; PROTEIN PROCESSING;

AGING; ANIMALS; BLOOD PROTEINS; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HUMANS; KUPFFER CELLS; LIPOXYGENASE; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; NITROSATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIDOREDUCTASES; PEROXIDASE; PEROXIREDOXINS; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; THIOREDOXINS; XANTHINE OXIDASE;

EID: 84896722961     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.01.010     Document Type: Review

References (82)

1. Sivan S.-S., et al. Collagen turnover in normal and degenerate human intervertebral discs as determined by the racemization of aspartic acid. Int. J. Biol. Chem. 2008, 283(14):8796-8801.
2. Schmucker D.L. Age-related changes in liver structure and function: implications for disease?. Exp. Gerontol. 2005, 40(8-9):650-659.
3. Griffiths H.R., et al. Biomarkers. Mol. Aspects Med. 2002, 23(1-3):101-208.
4. Shi T., et al. IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery. Methods 2012, 56(2):246-253.
5. Ushioda R., et al. ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER. Science 2008, 321(5888):569-572.
6. Bulleid N.J., Ellgaard L. Multiple ways to make disulfides. Trends Biochem. Sci 2011, 36(9):485-492.
7. Appenzeller-Herzog C., et al. Disulphide production by Ero1α-PDI relay is rapid and effectively regulated. EMBO J. 2010, 29(19):3318-3329.
8. Nguyen V.D., et al. Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulfide bond formation. J. Mol. Biol. 2011, 406(3):503-515.
9. Appenzeller-Herzog C., et al. A novel disulphide switch mechanism in Ero1alpha balances ER oxidation in human cells. EMBO J 2008, 27(22):2977-2987.
10. Appenzeller-Herzog C., Ellgaard L. In vivo reduction-oxidation state of protein disulfide isomerase: the two active sites independently occur in the reduced and oxidized forms. Antioxid Redox Signaling 2008, 10(1):55-64.
11. Kakihana T., et al. Dynamic regulation of Ero1alpha and peroxiredoxin 4 localization in the secretory pathway. J. Biol. Chem 2013, 288(41):29586-29594.
12. Jessop C.E., Bulleid N.J. Glutathione directly reduces an oxidoreductase in the endoplasmic reticulum of mammalian cells. Int. J. Biol. Chem. 2004, 279(53):55341-55347.
13. Schulman S., et al. Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partners. Proc. Nat. Acad. Sci. U.S.A 2010, 107(34):15027-15032.
14. Lodish H.F., Kong N. The secretory pathway is normal in dithiothreitol-treated cells, but disulfide-bonded proteins are reduced and reversibly retained in the endoplasmic reticulum. J. Biol. Chem 1993, 268(27):20598-20605.
15. Basso M., et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J. Biol. Chem 2013, 288(22):15699-15711.
16. Soderberg A., et al. Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic. Biol. Med. 2007, 43(1):90-99.
17. Eldh M., et al. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One 2010, 5(12):e15353.
18. Janiszewski M., et al. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit. Care Med. 2004, 32(3):818-825.
19. Aoki N., et al. Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 2007, 148(8):3850-3862.
20. Dunston C.R., Choudhury K., Griffiths H.R. Terminal galactose residues on transferrin are increased in midlife adults compared to young adults. Proteomics 2012, 12(21):3147-3153.
21. Griffiths H.R., Lunec J. The effects of oxygen free radicals on the carbohydrate moiety of IgG. FEBS Lett 1989, 245(1-2):95-99.
22. Bodman K.B., et al. Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro. Clin. Exp. Immunol 1992, 88(3):420-423.
23. Vanhooren V., et al. Alteration in N-glycomics during mouse aging: a role for FUT8. Aging Cell 2011, 10(6):1056-1066.
24. Mimura Y., et al. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol. Immunol 2000, 37(12-13):697-706.
25. Ansar W., et al. Disease-associated glycosylated molecular variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis. Glycoconj. J 2009, 26(9):1151-1169.
26. Cullen P., et al. Downregulation of the selectin ligand-producing fucosyltransferases Fuc-TIV and Fuc-TVII during foam cell formation in monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol 1997, 17(8):1591-1598.
27. Tarr T.J.M., et al. Cellular crosstalk between TNF-alpha, NADPH oxidase, PKCbeta2, and C2GNT in human leukocytes. Cell Signalling 2012, 24(4):873-878.
28. Perkins B.A., et al. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. PLoS One 2012, 7(4):e35655.
29. Radi R., et al. Reaction of xanthine oxidase-derived oxidants with lipid and protein of human plasma. Arch. Biochem. Biophys 1991, 286(1):117-125.
30. Atkinson K.R., et al. An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia. J. Lipid Res 2009, 50(1):71-80.
31. Brock J.W., et al. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J. Lipid Res 2008, 49(4):847-855.
32. Rabbani N., et al. Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. Diabetes 2010, 59(4):1038-1045.
33. Shao B., Pennathur S., Heinecke J.W. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. J. Biol. Chem 2012, 287(9):6375-6386.
34. Vaisar T., et al. HDL in humans with cardiovascular disease exhibits a proteomic signature. Clin. Chim. Acta 2010, 411(13-14):972-979.
35. Weber D., et al. Measurement of HNE-protein adducts in human plasma and serum by ELISA-comparison of two primary antibodies. Redox Biol. 2013, 1(1):226-233.
36. Griffiths H.R. Antioxidants and protein oxidation. Free Radic Res 2000, 33(Suppl.):S47-S58.
37. Brown D.I., Griendling K.K. Nox proteins in signal transduction. Free Radic. Biol. Med 2009, 47(9):1239-1253.
38. Laurindo F.R., et al. Novel role of protein disulfide isomerase in the regulation of NADPH oxidase activity: pathophysiological implications in vascular diseases. Antioxid Redox Signalling 2008, 10(6):1101-1113.
39. Santos C.X., et al. Protein disulfide isomerase (PDI) associates with NADPH oxidase and is required for phagocytosis of Leishmania chagasi promastigotes by macrophages. J. Leukoc. Biol 2009, 86(4):989-998.
40. de A.P.A.M., et al. Protein disulfide isomerase redox-dependent association with p47(phox): evidence for an organizer role in leukocyte NADPH oxidase activation. J. Leukoc. Biol. 2011, 90(4):799-810.
41. Pescatore L.A., et al. Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation. J. Biol. Chem 2012, 287(35):29290-29300.
42. Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. Regul. Integr. Comp. Physiol 2004, 287(5):R1014-R1030.
43. Mitchell L., et al. Redox regulation of Ras and Rho GTPases: mechanism and function. Antioxid Redox Signalling 2013, 18(3):250-258.
44. Jin S., et al. Lipid raft redox signaling: molecular mechanisms in health and disease. Antioxid Redox Signalling 2011, 15(4):1043-1083.
45. Dias I.H., et al. Sulforaphane restores cellular glutathione levels and reduces chronic periodontitis neutrophil hyperactivity in vitro. PLoS One 2013, 8(6):e66407.
46. Allen E.M., et al. Oxidative and inflammatory status in Type 2 diabetes patients with periodontitis. J. Clin. Periodontol. 2011, 38(10):894-901.
47. Go Y.M., Jones D.P. Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta 2008, 1780(11):1273-1290.
48. Go Y.M., et al. A key role for mitochondria in endothelial signaling by plasma cysteine/cystine redox potential. Free Radic. Biol. Med 2010, 48(2):275-283.
49. Griffiths H.R., et al. Free radicals and redox signalling in T-cells during chronic inflammation and ageing. Biochem. Soc. Trans 2011, 39(5):1273-1278.
50. Selvakumar B., et al. Co-regulation of constitutive nitric oxide synthases and NADPH oxidase by the small GTPase Rac. FEBS Lett 2008, 582(15):2195-2202.
51. Sabuncuoglu S., et al. Oxidative protein damage with carbonyl levels and nitrotyrosine expression after chemotherapy in bone marrow transplantation patients. Pharmacology 2012, 89(5-6):283-286.
52. Chen C., et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am. J. Physiol. Heart Circ. Physiol 2010, 299(1):H193-H201.
53. Chen C.A., et al. Redox modulation of endothelial nitric oxide synthase by glutaredoxin-1 through reversible oxidative post-translational modification. Biochemistry 2013, 52(38):6712-6723.
54. Chen C.A., et al. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J. Biol. Chem. 2008, 283(40):27038-27047.
55. Siow R.C., et al. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic. Biol. Med. 2007, 42(7):909-925.
56. Recchiuti A., Serhan C. Pro-resolvin lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation. Front. Immunol. 2012, 3:1-23.
57. Barrett T.J., et al. Inactivation of thiol-dependent enzymes by hypothiocyanous acid: role of sulfenyl thiocyanate and sulfenic acid intermediates. Free Radic. Biol. Med. 2012, 52(6):1075-1085.
58. Queiroz R.F., et al. Nitroxides attenuate carrageenan-induced inflammation in rat paws by reducing neutrophil infiltration and the resulting myeloperoxidase-mediated damage. Free Radic. Biol. Med. 2012, 53(10):1942-1953.
59. Talib J., et al. High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine. Free Radic. Biol. Med. 2012, 53(1):20-29.
60. Griffiths H.R. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?. Autoimmun. Rev. 2008, 7(7):544-549.
61. Dodon M.D., Quash G.A. The antigenicity of asialylated IgG: its relationship to rheumatoid factor. Immunology 1981, 42(3):401-408.
62. Clemens D.L., et al. Impairment of the asialoglycoprotein receptor by ethanol oxidation. Biochem. Pharmacol. 1996, 52(10):1499-1505.
63. Indolfi G., et al. Autoimmunity and extrahepatic manifestations in treatment-naive children with chronic hepatitis C virus infection. Clin. Dev. Immunol. 2012, 2012:785627.
64. Armengol C., et al. Role of scavenger receptors in the pathophysiology of chronic liver diseases. Crit. Rev. Immunol. 2013, 33(1):57-96.
65. Marsche G., et al. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J. Biol. Chem. 2003, 278(48):47562-47570.
66. Rubartelli A., et al. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 1992, 267(34):24161-24164.
67. Carilho Torrao R.B., et al. Healthy ageing and depletion of intracellular glutathione influences T cell membrane thioredoxin-1 levels and cytokine secretion. Chem. Cent. J. 2013, 7(1):150.
68. Wang P., et al. Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism. J. Biol. Chem 2013, 288(5):3346-3358.
69. Popescu N.I., Lupu C., Lupu F. Role of PDI in regulating tissue factor: FVIIa activity. Thromb. Res. 2010, 125(Suppl. 1):S38-S41.
70. Chen V.M. Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange. Semin. Thromb. Hemost 2013, 39(1):40-47.
71. Giannakopoulos B., et al. Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis. J. Autoimmun 2012, 39(3):121-129.
72. Curbo S., et al. Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides. Biochem. Biophys. Res. Commun. 2009, 390(4):1272-1277.
73. King B.C., et al. Truncated and full-length thioredoxin-1 have opposing activating and inhibitory properties for human complement with relevance to endothelial surfaces. J. Immunol. 2012, 188(8):4103-4112.
74. Metcalfe C., Cresswell P., Barclay A.N. Interleukin-2 signalling is modulated by a labile disulfide bond in the CD132 chain of its receptor. Open Biol. 2012, 2(1):110-136.
75. Auwerx J., et al. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication. Int. J. Biochem. Cell Biol. 2009, 41(6):1269-1275.
76. Passam F.H., et al. Redox control of beta2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1. J. Thromb. Haemost. 2010, 8(8):1754-1762.
77. Swiatkowska M., et al. Ero1alpha is expressed on blood platelets in association with protein-disulfide isomerase and contributes to redox-controlled remodeling of alphaIIbbeta3. J. Biol. Chem. 2010, 285(39):29874-29883.
78. Swiatkowska M., et al. Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells. FEBS J. 2008, 275(8):1813-1823.
79. Holbrook L.M., et al. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function. J. Thromb. Haemost. 2012, 10(2):278-288.
80. Willems S.H., et al. Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem. J. 2010, 428(3):439-450.
81. Murphy, D., et al., Regulation of platelet activity in a changing redox environment. Antioxid Redox Signalling, 2013.
82. Ambruso D.R., et al. Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activity. Biochim. Biophys. Acta 2012, 1823(2):306-315.